cell type: Normal prostate epithelial cells (PrEC)
time point: 6 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Normal prostate epithelial cells (PrEC)
time point: 6 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Normal prostate epithelial cells (PrEC)
time point: 6 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Normal prostate epithelial cells (PrEC)
time point: 6 hours
treated with: Sulforaphane (SFN)
cell type: Normal prostate epithelial cells (PrEC)
time point: 6 hours
treated with: Sulforaphane (SFN)
cell type: Normal prostate epithelial cells (PrEC)
time point: 6 hours
treated with: Sulforaphane (SFN)
cell type: Normal prostate epithelial cells (PrEC)
time point: 24 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Normal prostate epithelial cells (PrEC)
time point: 24 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Normal prostate epithelial cells (PrEC)
time point: 24 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Normal prostate epithelial cells (PrEC)
time point: 24 hours
treated with: Sulforaphane (SFN)
cell type: Normal prostate epithelial cells (PrEC)
time point: 24 hours
treated with: Sulforaphane (SFN)
cell type: Normal prostate epithelial cells (PrEC)
time point: 24 hours
treated with: Sulforaphane (SFN)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 6 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 6 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 6 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 6 hours
treated with: Sulforaphane (SFN)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 6 hours
treated with: Sulforaphane (SFN)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 6 hours
treated with: Sulforaphane (SFN)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 24 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 24 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 24 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 24 hours
treated with: Sulforaphane (SFN)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 24 hours
treated with: Sulforaphane (SFN)
cell type: Androgen-dependent prostate cancer epithelial cells (LNCaP)
time point: 24 hours
treated with: Sulforaphane (SFN)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 6 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 6 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 6 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 6 hours
treated with: Sulforaphane (SFN)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 6 hours
treated with: Sulforaphane (SFN)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 6 hours
treated with: Sulforaphane (SFN)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 24 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 24 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 24 hours
treated with: Dimethyl sulfoxide (DMSO; vehicle control)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 24 hours
treated with: Sulforaphane (SFN)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 24 hours
treated with: Sulforaphane (SFN)
cell type: androgen-independent prostate cancer epithelial cells (PC-3)
time point: 24 hours
treated with: Sulforaphane (SFN)